0,909  0,003  Caspase 9 stimulant
0,895  0,005  Antiinflammatory
0,848  0,003  Caspase 3 stimulant
0,758  0,022  Apoptosis agonist
0,718  0,019  Transcription factor NF kappa B inhibitor
0,632  0,009  Immunosuppressant
0,609  0,010  NOS3 expression inhibitor
0,604  0,010  Antiosteoporotic
0,595  0,015  Bone diseases treatment
0,592  0,012  Antipruritic, allergic
0,579  0,014  Chemopreventive
0,575  0,039  Antineoplastic (breast cancer)
0,543  0,016  AR expression inhibitor
0,534  0,013  Nitric oxide antagonist
0,526  0,017  Proliferative diseases treatment
0,507  0,002  Antipruritic, non-allergic
0,517  0,019  Hepatic disorders treatment
0,506  0,011  ICAM1 expression inhibitor
0,511  0,027  Respiratory analeptic
0,519  0,042  TNF expression inhibitor
0,487  0,030  Antiallergic
0,467  0,018  Hypoxia-inducible factor 1 alpha inhibitor
0,470  0,024  Apoptosis antagonist
0,444  0,006  Lipocortins synthesis antagonist
0,483  0,046  Antibacterial
0,478  0,049  Antineoplastic (lung cancer)
0,449  0,034  Antihypercholesterolemic
0,424  0,009  Interferon gamma antagonist
0,442  0,031  Cytotoxic
0,417  0,013  Contraceptive
0,417  0,013  Abortion inducer
0,410  0,014  Sodium/bile acid cotransporter inhibitor
0,405  0,015  Growth hormone agonist
0,398  0,031  UGT2B4 substrate
0,421  0,057  Antileukemic
0,374  0,016  Hepatoprotectant
0,396  0,039  Analeptic
0,367  0,024  UDP-glucuronosyltransferase substrate
0,377  0,037  NOS2 expression inhibitor
0,340  0,019  UGT2B7 substrate
0,371  0,054  Antifungal
0,407  0,090  Antiarthritic
0,322  0,005  Farnesoid X receptor antagonist
0,363  0,048  Lipoprotein disorders treatment
0,311  0,009  UGT2B9 substrate
0,345  0,044  Sensitization
0,360  0,060  Cholesterol antagonist
0,351  0,051  Cardioprotectant
0,319  0,026  Dual specificity phosphatase 3 inhibitor
0,305  0,014  Antipruritic
0,289  0,007  Antieczematic
0,298  0,020  Hair growth stimulant
0,371  0,098  Analgesic
0,323  0,050  Antineoplastic (endocrine cancer)
0,325  0,053  Antioxidant
0,272  0,004  CDC25A inhibitor
0,297  0,031  UGT1A4 substrate
0,303  0,038  Antihypertriglyceridemic
0,345  0,080  CYP3A4 substrate
0,324  0,060  Antineoplastic (pancreatic cancer)
0,329  0,065  Calcium channel activator
0,310  0,063  Antineoplastic (osteosarcoma)
0,308  0,073  Antipsoriatic
0,353  0,120  Cyclophilin D inhibitor
0,353  0,120  Antidiabetic
0,260  0,028  Antiacne
0,318  0,088  Vasodilator, peripheral
0,265  0,035  Dual specificity phosphatase inhibitor
0,237  0,009  Arachidonic acid antagonist
0,309  0,081  Prostate cancer treatment
0,255  0,033  Prostatic (benign) hyperplasia treatment
0,255  0,040  P-glycoprotein inhibitor
0,245  0,033  Antiviral (Herpes)
0,274  0,063  Antiprotozoal (Leishmania)
0,317  0,113  CYP2C19 inhibitor
0,233  0,031  Prostate disorders treatment
0,264  0,062  Antineoplastic (lymphoma)
0,261  0,063  Antiglaucomic
0,254  0,058  Antiulcerative
0,267  0,072  Chemoprotective
0,207  0,014  Growth stimulant
0,274  0,081  Antineoplastic (melanoma)
0,222  0,030  Toxic, respiratory center
0,279  0,089  Antineoplastic (colorectal cancer)
0,265  0,086  Antineoplastic (ovarian cancer)
0,266  0,088  Antineoplastic (colon cancer)
0,180  0,003  Na+ K+ transporting ATPase inhibitor
0,192  0,017  Adenylate cyclase stimulant
0,230  0,055  UGT1A1 substrate
0,247  0,073  Embryotoxic
0,249  0,079  Antineoplastic (renal cancer)
0,233  0,066  Antiviral (HIV)
0,176  0,009  SULT1E1 substrate
0,255  0,089  CYP2C19 substrate
0,267  0,101  Interleukin 2 agonist
0,170  0,005  Anticholelithogenic
0,178  0,025  Antineoplastic antibiotic
0,203  0,050  Thrombolytic
0,175  0,023  Alcohol dehydrogenase substrate
0,188  0,039  Bone formation stimulant
0,161  0,013  Anabolic
0,154  0,007  Glycine receptor antagonist
0,185  0,038  Antifungal enhancer
0,152  0,005  Opioid kappa receptor agonist
0,194  0,049  Protein-tyrosine phosphatase inhibitor
0,179  0,035  Protein-tyrosine phosphatase 1B inhibitor
0,243  0,099  Immunostimulant
0,149  0,007  Androgen agonist
0,227  0,086  DNA synthesis inhibitor
0,145  0,012  Interleukin 5 antagonist
0,148  0,016  UGT2B11 substrate
0,215  0,085  Hypolipemic
0,128  0,005  Potassium channel Kv1.3 blocker
0,179  0,056  UGT2B10 substrate
0,175  0,053  NOS3 expression enhancer
0,209  0,087  RNA-directed DNA polymerase inhibitor
0,123  0,003  Lipocortins synthesis agonist
0,210  0,090  Angiogenesis stimulant
0,171  0,056  UGT2B15 substrate
0,168  0,056  Protein kinase stimulant
0,149  0,038  Microtubule formation inhibitor
0,240  0,130  Antihypertensive
0,215  0,108  Spasmolytic
0,202  0,099  Antineoplastic (cervical cancer)
0,181  0,079  Carcinogenic
0,207  0,106  Hypoglycemic
0,185  0,084  Antiviral (Influenza)
0,122  0,021  Contraceptive male
0,101  0,005  Glucocorticoid antagonist
0,161  0,065  Antiviral (Influenza A)
0,170  0,077  Antineoplastic (bone cancer)
0,121  0,030  ABCA1 expression enhancer
0,107  0,016  Postmenopausal disorders treatment
0,105  0,018  Glycine receptor agonist
0,243  0,156  CYP2C9 substrate
0,185  0,102  Teratogen
0,116  0,034  Actinic keratosis treatment
0,090  0,009  Postcoital contraceptive
0,186  0,106  VCAM1 expression inhibitor
0,110  0,031  Transcription factor NF kappa B stimulant
0,097  0,018  Estrogen agonist
0,101  0,023  Narcotic antagonist
0,125  0,049  Choleretic
0,122  0,051  Estrogen antagonist
0,222  0,152  Antithrombotic
0,128  0,058  Cholesterol synthesis inhibitor
0,131  0,061  DNA polymerase I inhibitor
0,071  0,003  Glucocorticoid agonist
0,097  0,030  Antiviral (Dengue virus)
0,180  0,116  Antineoplastic (lymphocytic leukemia)
0,082  0,021  Antimycoplasmal
0,105  0,044  Antineoplastic alkaloid
0,257  0,197  Calcium channel L-type activator
0,124  0,066  Antiviral (Hepatitis B)
0,159  0,103  Antiviral (Hepatitis)
0,168  0,112  Neurotrophic factor enhancer
0,119  0,064  Constipation treatment
0,157  0,102  Antihelmintic
0,180  0,125  Cardiovascular analeptic
0,127  0,073  Antihemorrhagic
0,099  0,047  Androgen antagonist
0,201  0,149  Antimycobacterial
0,061  0,010  Parathyroid hormone antagonist
0,128  0,078  CC chemokine 6 receptor antagonist
0,130  0,080  Antineoplastic (squamous cell carcinoma)
0,051  0,003  Corticosteroid-like
0,058  0,011  RNA-directed RNA polymerase stimulant
0,176  0,129  Tumour necrosis factor alpha release inhibitor
0,240  0,194  Alpha-glucosidase inhibitor
0,086  0,041  Analgesic, opioid
0,100  0,056  DNA directed RNA polymerase inhibitor
0,076  0,032  SULT2A1 substrate
0,140  0,097  Melanin inhibitor
0,122  0,082  Skin whitener
0,188  0,149  Antidiabetic (type 2)
0,125  0,087  Psychosexual dysfunction treatment
0,088  0,050  Inducible nitric-oxide synthase inhibitor
0,052  0,017  Estrogen receptor alpha agonist
0,100  0,065  Estrogen receptor beta antagonist
0,137  0,102  Macular degeneration treatment
0,065  0,034  Heme oxygenase stimulant
0,155  0,126  Antiparasitic
0,151  0,123  Antirickettsial
0,197  0,175  CYP3A4 inhibitor
0,042  0,021  Farnesoid X receptor agonist
0,050  0,029  Microtubule stabilization
0,099  0,078  Endometrios treatment
0,061  0,041  Aromatase inhibitor
0,054  0,035  Opioid agonist
0,109  0,090  Contraceptive female
0,141  0,125  Interleukin antagonist
0,036  0,020  Tubulin agonist
0,041  0,026  Cholesterol absorption inhibitor
0,171  0,157  Antituberculosic
0,022  0,010  Progesterone agonist
0,061  0,050  CDC25B inhibitor
0,019  0,009  Telomerase stimulant
0,090  0,080  Expectorant
0,066  0,058  Calcium channel L-type blocker
0,049  0,042  Glucose-6-phosphate translocase inhibitor
0,048  0,042  Protein 50S ribosomal subunit inhibitor
0,126  0,122  Aldose reductase substrate
0,185  0,181  Immunomodulator
0,019  0,018  Estrone sulfatase inhibitor
0,021  0,019  Vitamin D receptor antagonist
0,131  0,130  Wound healing agent

